Evidence map›Paper›PMID 30239918›Full record

ArticleJournal of neuropathology and experimental neurology2018

A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.

Jennifer W Koehler, Andrew D Miller, C Ryan Miller, Brian Porter, Kenneth Aldape, Jessica Beck, Daniel Brat, Ingrid Cornax, Kara Corps, Chad Frank and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 139 citations in OpenAlex.

  1. A case of oligodendroglioma in a sea otter (Enhydra lutris).The Journal of veterinary medical science · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Adapting Laser Interstitial Thermal Therapy for the Treatment of Naturally Occurring Intracranial Tumors in Dogs.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Oligosarcoma with chondroid metaplasia in a French bulldog.The Journal of veterinary medical science · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 1 country.

Jennifer W KoehlerDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, Alabama.
Andrew D MillerDepartment of Biomedical Sciences, Section of Anatomic Pathology, College of Veterinary Medicine, Cornell University, Ithaca, New York.
C Ryan MillerDepartment of Pathology and Laboratory Medicine.
Brian PorterDepartment of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas.
Kenneth AldapeLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Jessica BeckLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Daniel BratDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Ingrid CornaxDepartment of Pediatrics, University of California-San Diego, San Diego California.
Kara CorpsNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Viral Immunology and Intravital Imaging Section, Bethesda, Maryland.
Chad FrankDepartment of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Ft. Collins, Colorado.
Caterina GianniniDivision of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota.
Craig HorbinskiDepartment of Pathology.
Jason T HuseDepartments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
M Gerard O'SullivanMasonic Cancer Center Comparative Pathology Shared Resource and Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota.
Daniel R RissiDepartment of Pathology and Athens Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Georgia, Athens, Georgia.
R Mark SimpsonCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Molecular Pathology Unit, Laboratory of Cancer Biology and Genetics, Bethesda, Maryland.
Kevin WoolardDepartment of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California-Davis, Davis, California.
Joanna H ShihBiometrics Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Christina MazckoComparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Mark R GilbertNational Institute of Neurological Disorders and Stroke and the Center for Cancer Research, National Cancer Institute, National Institutes of Health, NeuroOncology Branch, Bethesda, Maryland.
Amy K LeBlancNational Cancer Institute, National Institutes of Health, Comparative Oncology Program, Center for Cancer Research, Bethesda, Maryland.
Center for Cancer Research · USNational Institutes of Health · USNorthwestern University · USAuburn University · USColorado State University · USCornell University · USMayo Clinic · USNational Cancer Institute · USTexas A&M University · USThe University of Texas MD Anderson Cancer Center · USUniversity of California, Davis · USUniversity of California, San Diego · USUniversity of Georgia · USUniversity of Minnesota · USUniversity of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
COP LaboratoryZIABC011692 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEBLANC, AMY · 2016 to 2025
$15.5M
Tissue Factor as a Key Determinant of IDH1 Mutant versus IDH1 Wild-type Glioma Thrombosis and MalignancyR01NS102669 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HORBINSKI, CRAIG MICHAEL · 2017 to 2021
$1.7M
Comparative Brain Tumor ConsortiumZIABC011696 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEBLANC, AMY · 2016 to 2025
$859k
Comparative Oncology Trials ConsortiumZIGBC011689 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEBLANC, AMY · 2016 to 2025
$859k
NCI NIH HHS P30 CA016086NINDS NIH HHS R01 NS102669
6 · The paper itself

Abstract

The National Cancer Institute-led multidisciplinary Comparative Brain Tumor Consortium (CBTC) convened a glioma pathology board, comprising both veterinarian and physician neuropathologists, and conducted a comprehensive review of 193 cases of canine glioma. The immediate goal was to improve existing glioma classification methods through creation of a histologic atlas of features, thus yielding greater harmonization of phenotypic characterization. The long-term goal was to support future incorporation of clinical outcomes and genomic data into proposed simplified diagnostic schema, so as to further bridge the worlds of veterinary and physician neuropathology and strengthen validity of the dog as a naturally occurring, translationally relevant animal model of human glioma. All cases were morphologically reclassified according to a new schema devised by the entire board, yielding a majority opinion diagnosis of astrocytoma (43, 22.3%), 19 of which were low-grade and 24 high-grade, and oligodendroglioma (134, 69.4%), 35 of which were low-grade and 99 were high-grade. Sixteen cases (8.3%) could not be classified as oligodendroglioma or astrocytoma based on morphology alone and were designated as undefined gliomas. The simplified classification scheme proposed herein provides a tractable means for future addition of molecular data, and also serves to highlight histologic similarities and differences between human and canine glioma.

Indexed as

2',3'-Cyclic-Nucleotide PhosphodiesterasesAnimalsBrainBrain NeoplasmsDiagnosis, DifferentialDogsFemaleGlial Fibrillary Acidic ProteinGliomaIntermediate FilamentsKi-67 AntigenMaleOligodendrocyte Transcription Factor 2PhysiciansVeterinarians2',3'-Cyclic-Nucleotide PhosphodiesterasesGlial Fibrillary Acidic ProteinKi-67 AntigenOligodendrocyte Transcription Factor 2

Identifiers

PMID30239918
PMCPMC6181180
OpenAlexW2890902697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.